On the surface, Mesa Laboratories (NASDAQ:MLAB) looks interesting. This is a company with 60% gross margins and 20% operating margins in an attractive industry. However, when I take a closer look at the business, I realize that all the growth is generated by acquisitions and that the company is only growing 2% organically. Hence, investors are paying 5 times sales for a rollup with almost zero organic growth. Furthermore, not only is the stock highly illiquid, but insiders have been quietly, but aggressively, selling their shares. The company also continues to lever up the balance sheet while trying to convince shareholders that they will be able to create synergies from all the acquisitions they have made (four in...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|
|PRO Top long ideas returned 21.7% in 2016**|